United Therapeutics
UTHR
#1025
Rank
S$29.71 B
Marketcap
S$692.78
Share price
-5.19%
Change (1 day)
21.24%
Change (1 year)

Market capitalization of United Therapeutics (UTHR)

Market cap: S$29.71 Billion

As of October 2026 United Therapeutics has a market cap of S$29.71 Billion. This makes United Therapeutics the world's 1025th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of United Therapeutics from 1999 to 2026

End of year Market Cap

Year Marketcap Change
2026S$29.71 B0.9%
2025S$29.44 B34.82%
2024S$21.84 B60.06%
2023S$13.64 B-19.68%
2022S$16.99 B29.15%
2021S$13.15 B47.42%
2020S$8.92 B71.25%
2019S$5.21 B-19.64%
2018S$6.48 B-24.16%
2017S$8.55 B-2.89%
2016S$8.80 B-13.14%
2015S$10.13 B25.77%
2014S$8.06 B11.65%
2013S$7.21 B120.28%
2012S$3.27 B-8.19%
2011S$3.56 B-23.84%
2010S$4.68 B16.95%
2009S$4.00 B92.88%
2008S$2.07 B-33.53%
2007S$3.12 B74.61%
2006S$1.79 B-33.28%
2005S$2.68 B62.44%
2004S$1.65 B98.82%
2003S$0.83 B37.05%
2002S$0.60 B55.55%
2001S$0.38 B-25.39%
2000S$0.52 B-57.38%
1999S$1.22 B

End of Day market cap according to different sources

On Oct 2nd, 2026 the market cap of United Therapeutics was reported to be:

S$29.71 Billion
by Nasdaq info icon info icon
S$29.71 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
S$202.64 B 581.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$1.302 T 4,284.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
S$15.53 B-47.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$229.52 B 672.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
S$67.60 B 127.53%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$120.50 B 305.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cytokinetics
CYTK
S$11.66 B-60.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$58.96 B 98.43%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel